SHA:600062 Market Cap

SHA:600062 has a market cap or net worth of 18.47 billion as of April 28, 2026. Its market cap has decreased by -4.88% in one year.

Market Cap

18.47B

Enterprise Value

17.97B

Revenue

10.73B

Ranking

n/a

PE Ratio

11.40

Stock Price

17.92

Market Cap Chart

Since March 1, 2004, SHA:600062's market cap has increased from 9.40B to 18.47B, an increase of 96.37%. That is a compound annual growth rate of 3.09%.

Market Cap History

Date	Market Cap	% Change
Apr 28, 2026	18.47B	-2.22%
Dec 31, 2025	18.89B	-7.08%
Dec 31, 2024	20.32B	5.43%
Dec 29, 2023	19.28B	5.47%
Dec 30, 2022	18.28B	31.03%
Dec 31, 2021	13.95B	11.51%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Tonghua Dongbao Pharmaceutical	18.68B
Fujian Cosunter Pharmaceutical	18.04B
Walvax Biotechnology	19.00B
Hybio Pharmaceutical	19.20B
Joincare Pharmaceutical Group Industry	19.33B
Wanbangde Pharmaceutical Holding Group	17.52B
China Resources Jiangzhong Pharmaceutical Co.,Ltd	17.43B
Shandong Buchang Pharmaceuticals	17.28B

Market Cap Rankings